A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment
Authors:
- Yang XingYXYang Xing
- Feroza YasinjanFYFeroza Yasinjan
- Mei YangMYMei Yang
- Yajie DuYDYajie Du
- Huayue GengHGHuayue Geng
- Minghua HeMHMinghua He
- Yingtong WangYWYingtong Wang
- Jicheng SunJSJicheng Sun
- Wei JiangWJWei Jiang
- Ling ZhangLZLing Zhang
- Baofeng GuoBGBaofeng Guo
- Kelong FanKelong Fan
- 14 August 2023
- journal article
- review article
- Published by Elsevier in Nano Today
- Vol. 52
Abstract
No abstract availableKeywords
This publication has 311 references indexed in Scilit:
- Glioblastoma cancer stem cells – From concept to clinical applicationCancer Letters, 2013
- Liposome: classification, preparation, and applicationsDiscover Nano, 2013
- Mechanisms of Glioma-Associated NeovascularizationThe American Journal of Pathology, 2012
- Surface functionalization of nanoparticles for nanomedicineChemical Society Reviews, 2012
- Artesunate Induces Oxidative DNA Damage, Sustained DNA Double-Strand Breaks, and the ATM/ATR Damage Response in Cancer CellsMolecular Cancer Therapeutics, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Software survey: VOSviewer, a computer program for bibliometric mappingScientometrics, 2009
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent GlioblastomaJournal of Clinical Oncology, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007